Pharma major Roche may have earned over a hundred times what risdiplam, a drug used to treat spinal muscular atrophy (SMA), ...

Researchers studied 118 SMA type 2 patients and saw their RULM scores stayed higher than expected had their disease kept its ...

In this episode, Hannah and I tell the origin story of my disability, and how doctors eventually diagnosed me with Spinal ...

He hopes to have a lasting impact on others and plans to continue to raise awareness, promote inclusion, and embrace diversity in his community.

Biotech stock Scholar Rock ( SRRK 2.97%) was popular among investors on Wednesday after a positive new analyst note on the company made the rounds. This resulted in the stock bumping nearly 3% higher ...

I knew that I really needed to reach out to my community, but mainly reach out to the younger generation,” Zelaya says. “I ...

Jensen Caraballo, a beloved disability rights advocate in New York, has died at age 33. Born with spinal muscular atrophy, ...

Those with spinal muscular atrophy can get emotional support by building an SMA support system that includes SMA communities ...

The global antisense oligonucleotides market is poised for remarkable growth over the next decade, projected to rise from USD 2,913.5 million in 2023 to USD 5,519.6 million by 2033, according to ...

A generic version of Risdiplam, a medicine used to treat spinal muscular atrophy (SMA), could soon be available in India at $183.47 dollars per bottle, a sharp 97% drop from the current rate of $ ...

Luke was born with spinal muscular atrophy type 1 and scoliosis. In July 2020, a spring was inserted into his back by Surgeon A, when he was six years old. The family said this week it was a ...

Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients aged 2 and older without early treatment.